Thymosin β4 is not required for embryonic viability or vascular development.
Thymosin β4 is not required for embryonic viability or vascular development.
复制标题
DOI:
10.1161/circresaha.111.300197
复制
发表时间:
2013-02-01
影响因子:
20.1
通讯作者:
Chen J
中科院分区:
文献类型:
--
作者:
Banerjee I;Moore Morris T;Evans SM;Chen J
Rossdeutsch et al. describe a requirement for Thymosin β4 (Tβ4) in vascular development. Impaired mural cell migration, differentiation, partial embryonic lethality, and hemorrhaging were observed following analysis of two lines of mice, one of which was germline null for Tβ4, and another in which Tβ4 was knocked down by endothelial specific expression of Tβ4 shRNA. These data are in direct contrast to our published global and cardiac specific Tβ4 knockout lines. Thus the role of Tβ4 needs to be clarified to understand its importance in cardiovascular development. To investigate and clarify the role of Tβ4 in vascular smooth muscle cell development and vessel stability. Examination of Tβ4 global knockouts did not demonstrate embryonic hemorrhaging, altered mural cell development or lethality. Endothelial specific knockouts also did not exhibit any embryonic lethality and were viable to adulthood. Analysis of our Tβ4 global and cardiac- and endothelial-specific knockout models demonstrated that Tβ4 is dispensable for embryonic viability and vascular development.